Clinical trials & evidence

FDA Told a Promising ADC: Not Yet.

MOGAD May Finally Have a Clue to Who Relapses

Cholangiocarcinoma Just Made FGFR2 Testing Harder to Ignore

Depression Is Not One Score, and TMS Proves It

Breast Cancer Radiation De-Escalation Has an Adherence Problem

Clearing Amyloid Is Not the Same as Saving Cognition

Novo’s €1.165B Bet Targets the Burden of Weekly Injections

Small-Cell Lung Cancer May Be Done Irradiating Healthy Brains

Pembrolizumab Just Lost a Head-to-Head Survival Fight
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
